14347-18-3 Usage
Description
N-(5-ACETYL-2-HYDROXY-PHENYL)-METHANESULFONAMIDE is a chemical compound with the molecular formula C10H13NO4S. It is a sulfonamide derivative, which is a class of organic compounds known for their antibacterial and diuretic properties. This particular compound contains an acetyl group, a hydroxyphenyl group, and a methanesulfonamide group attached to a central nitrogen atom. It may have potential therapeutic uses due to its structure and properties, but further research and testing are necessary to determine its specific pharmacological activities and potential applications.
Uses
Used in Pharmaceutical Industry:
N-(5-ACETYL-2-HYDROXY-PHENYL)-METHANESULFONAMIDE is used as a potential therapeutic agent for various medical conditions due to its sulfonamide structure and properties. Its antibacterial and diuretic properties may contribute to its potential applications in treating infections and managing fluid retention.
Used in Research and Development:
N-(5-ACETYL-2-HYDROXY-PHENYL)-METHANESULFONAMIDE is used as a chemical intermediate in the synthesis of other pharmaceutical compounds. Its unique structure and properties make it a valuable candidate for further research and development to explore its potential applications in drug discovery and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 14347-18-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,3,4 and 7 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 14347-18:
(7*1)+(6*4)+(5*3)+(4*4)+(3*7)+(2*1)+(1*8)=93
93 % 10 = 3
So 14347-18-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO4S/c1-6(11)7-3-4-9(12)8(5-7)10-15(2,13)14/h3-5,10,12H,1-2H3
14347-18-3Relevant articles and documents
Fibrinogen receptor antagonists and their use
-
Page/Page column 78, (2010/08/04)
This invention relates to novel fused bicyclic compounds of the general formula (I): wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.